MacroGenics, Inc. (FRA:M55)

MacroGenics Statistics

Total Valuation

MacroGenics has a market cap or net worth of EUR 83.47 million. The enterprise value is -10.87 million.

Market Cap	83.47M
Enterprise Value	-10.87M

Important Dates

The last earnings date was Wednesday, November 19, 2025.

Earnings Date	Nov 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	63.26M
Shares Outstanding	n/a
Shares Change (YoY)	+0.95%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	2.38%
Owned by Institutions (%)	58.98%
Float	52.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
PB Ratio	1.46
P/TBV Ratio	1.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.17
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.08

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.55.

Current Ratio	5.22
Quick Ratio	4.85
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	-0.22
Interest Coverage	-26.97

Financial Efficiency

Return on equity (ROE) is -81.13% and return on invested capital (ROIC) is -54.99%.

Return on Equity (ROE)	-81.13%
Return on Assets (ROA)	-26.52%
Return on Invested Capital (ROIC)	-54.99%
Return on Capital Employed (ROCE)	-50.19%
Revenue Per Employee	318,990
Profits Per Employee	-189,670
Employee Count	341
Asset Turnover	0.48
Inventory Turnover	30.59

Taxes

In the past 12 months, MacroGenics has paid 894,063 in taxes.

Income Tax	894,063
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-60.71%
50-Day Moving Average	1.39
200-Day Moving Average	1.45
Relative Strength Index (RSI)	45.06
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.20

Income Statement

In the last 12 months, MacroGenics had revenue of EUR 108.78 million and -64.68 million in losses. Loss per share was -1.03.

Revenue	108.78M
Gross Profit	-47.60M
Operating Income	-96.81M
Pretax Income	-63.78M
Net Income	-64.68M
EBITDA	-90.40M
EBIT	-96.81M
Loss Per Share	-1.03

Balance Sheet

The company has 124.77 million in cash and 31.54 million in debt, giving a net cash position of 93.23 million.

Cash & Cash Equivalents	124.77M
Total Debt	31.54M
Net Cash	93.23M
Net Cash Per Share	n/a
Equity (Book Value)	57.10M
Book Value Per Share	0.90
Working Capital	159.91M

Cash Flow

In the last 12 months, operating cash flow was -138.47 million and capital expenditures -1.95 million, giving a free cash flow of -140.42 million.

Operating Cash Flow	-138.47M
Capital Expenditures	-1.95M
Free Cash Flow	-140.42M
FCF Per Share	n/a

Margins

Gross margin is -43.76%, with operating and profit margins of -89.00% and -59.46%.

Gross Margin	-43.76%
Operating Margin	-89.00%
Pretax Margin	-58.64%
Profit Margin	-59.46%
EBITDA Margin	-83.10%
EBIT Margin	-89.00%
FCF Margin	n/a

Dividends & Yields

MacroGenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.95%
Shareholder Yield	-0.95%
Earnings Yield	-77.49%
FCF Yield	-168.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MacroGenics has an Altman Z-Score of -6.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.01
Piotroski F-Score	2